CA2475069A1 - Derives amine utilises comme inhibiteurs de protease - Google Patents

Derives amine utilises comme inhibiteurs de protease Download PDF

Info

Publication number
CA2475069A1
CA2475069A1 CA002475069A CA2475069A CA2475069A1 CA 2475069 A1 CA2475069 A1 CA 2475069A1 CA 002475069 A CA002475069 A CA 002475069A CA 2475069 A CA2475069 A CA 2475069A CA 2475069 A1 CA2475069 A1 CA 2475069A1
Authority
CA
Canada
Prior art keywords
alkyl
halo
substituted
benzooxazol
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002475069A
Other languages
English (en)
Inventor
John O. Link
Valeri Martichonok
John W. Patterson
Oliver L. Saunders
Sheila Zipfel
Jana Burgess-Henry
Michael Graupe
Robert S. Mcdowell
Mary E. Mcgrath
Craig J. Mossman
David J. Aldous
Frank Halley
Justine Lai
Stephen D. Pickett
Sukanthini Thurairatnam
Andreas P. Timm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axys Pharmaceuticals Inc
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals, Inc.
John O. Link
Valeri Martichonok
John W. Patterson
Oliver L. Saunders
Sheila Zipfel
Jana Burgess-Henry
Michael Graupe
Robert S. Mcdowell
Mary E. Mcgrath
Craig J. Mossman
David J. Aldous
Frank Halley
Justine Lai
Stephen D. Pickett
Sukanthini Thurairatnam
Andreas P. Timm
Axys Pharmaceuticals, Inc.
Aventis Pharma Limited
Martelli, Arnold J.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals, Inc., John O. Link, Valeri Martichonok, John W. Patterson, Oliver L. Saunders, Sheila Zipfel, Jana Burgess-Henry, Michael Graupe, Robert S. Mcdowell, Mary E. Mcgrath, Craig J. Mossman, David J. Aldous, Frank Halley, Justine Lai, Stephen D. Pickett, Sukanthini Thurairatnam, Andreas P. Timm, Axys Pharmaceuticals, Inc., Aventis Pharma Limited, Martelli, Arnold J. filed Critical Aventis Pharmaceuticals, Inc.
Priority claimed from CA002367352A external-priority patent/CA2367352A1/fr
Publication of CA2475069A1 publication Critical patent/CA2475069A1/fr
Abandoned legal-status Critical Current

Links

CA002475069A 1999-03-15 2000-03-15 Derives amine utilises comme inhibiteurs de protease Abandoned CA2475069A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12442199P 1999-03-15 1999-03-15
US60/124,421 1999-03-15
CA002367352A CA2367352A1 (fr) 1999-03-15 2000-03-15 Derives amine utilises comme inhibiteurs de protease

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002367352A Division CA2367352A1 (fr) 1999-03-15 2000-03-15 Derives amine utilises comme inhibiteurs de protease

Publications (1)

Publication Number Publication Date
CA2475069A1 true CA2475069A1 (fr) 2000-09-21

Family

ID=32991601

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002475069A Abandoned CA2475069A1 (fr) 1999-03-15 2000-03-15 Derives amine utilises comme inhibiteurs de protease

Country Status (1)

Country Link
CA (1) CA2475069A1 (fr)

Similar Documents

Publication Publication Date Title
AU774664B2 (en) Amine derivatives as protease inhibitors
AU779177B2 (en) Novel compounds and compositions as protease inhibitors
CA2368122A1 (fr) Nouveaux composes et compositions utilises en qualite d'inhibiteurs de proteases
US20070049594A1 (en) Novel compounds and compositions as cathepsin inhibitors
CA2396257A1 (fr) Nouveaux composes et compositions utilises comme inhibiteurs de protease
EP2499121B1 (fr) Dérivés de l'oxazoline pour la traitement des desordres de la cns.
WO2001068645A2 (fr) Composes et compositions agissant comme inhibiteurs de proteines
US20040192742A1 (en) Novel compounds and compositions as cathepsin inhibitors
US20040142999A1 (en) Novel compounds and compositions as cathepsin inhibitors
US7662849B2 (en) Amidino compounds as cysteine protease inhibitors
US7101880B2 (en) Peptidic compounds as cysteine protease inhibitors
CA2506114A1 (fr) Derives de cyanomethyle en tant qu'inhibiteurs de la protease a cysteine
US20060135781A1 (en) Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof
CA2475069A1 (fr) Derives amine utilises comme inhibiteurs de protease
US20030199506A1 (en) Novel compounds and compositions as cathepsin S inhibitors
EP1516877A1 (fr) Derivés d'amine comme inhibiteurs de protease
US20030158231A1 (en) Sulfonamide compounds as protease inhibitors
AU2004201071A1 (en) Amine Derivatives as Protease Inhibitors
WO2002023784A2 (fr) Inhibiteurs de la cysteine protease
CA2449021A1 (fr) Composes et compositions d'inhibiteurs de cathepsine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead